| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1052738211 |
| P356 | DOI | 10.1007/BF00426592 |
| P953 | full work available at URL | http://link.springer.com/content/pdf/10.1007/BF00426592.pdf |
| http://link.springer.com/article/10.1007/BF00426592/fulltext.html | ||
| http://link.springer.com/content/pdf/10.1007/BF00426592 | ||
| P698 | PubMed publication ID | 403551 |
| P2093 | author name string | M. M. Ghoneim | |
| S. P. Mewaldt | |||
| P2860 | cites work | The Control of Short-Term Memory / Richard C. Atkinson and Richard M. Shiffrin. - (1971) | Q34228091 |
| New concepts on the mechanism of action of benzodiazepines | Q36582476 | ||
| Action of the benzodiazepines on the cholinergic system | Q38162041 | ||
| Drug therapy. Anticholinergics | Q39872668 | ||
| Interaction of physostigmine and delta-9-tetrahydrocannabinol in man | Q41066652 | ||
| The cholinergic synapse and the site of memory | Q41511695 | ||
| The treatment of scopolamine-induced delirium with physostigmine | Q42240111 | ||
| The effects of drugs on learning in a simple preparation | Q46950774 | ||
| Memory. Autopsy findings and comments on the role of hippocampus in experiential recall | Q48523103 | ||
| Effect of diazepam on mouse whole brain and brain area acetylcholine and choline levels | Q48540970 | ||
| Human memory and the cholinergic system. A relationship to aging? | Q48584703 | ||
| The action of sedatives on brain stem oculomotor systems in man | Q48841867 | ||
| EFFECTS OF BENZODIAZEPINES ON CENTRAL NERVOUS SYSTEM OF CAT. | Q51273747 | ||
| Effects of diazepam and scopolamine on storage, retrieval and organizational processes in memory | Q67360031 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | L-scopolamine | Q337188 |
| diazepam | Q210402 | ||
| pharmacology | Q128406 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 1-6 | |
| P577 | publication date | 1977-03-01 | |
| 1977-03-23 | |||
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Studies on human memory: The interactions of diazepam, scopolamine, and physostigmine | |
| P478 | volume | 52 |
| Q45946052 | A comparison of the effects of scopolamine and diazepam on acquisition and retention of inhibitory avoidance in mice. |
| Q51721172 | A comparison of the effects of scopolamine and diazepam on working memory. |
| Q50421796 | A network model of behavioural performance in a rule learning task |
| Q37878781 | Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification |
| Q51849529 | Adverse effects of single therapeutic doses of diazepam on performance in normal geriatric subjects: relationship to plasma concentrations. |
| Q92402680 | Alzheimer's Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts |
| Q46097393 | Amnestic Effects of Intravenous Diazepam in Healthy Young Men |
| Q28210334 | Assessment of a cholinergic contribution to chlordiazepoxide-induced deficits of place learning in the Morris water maze |
| Q42079055 | Bacopa monniera Attenuates Scopolamine-Induced Impairment of Spatial Memory in Mice |
| Q39228650 | Benzodiazepines potentiate GABA-dopamine stereotyped dependent gnawing in mice |
| Q41122353 | Cholinergic activity and constraints on information processing |
| Q52165835 | Cholinergic agents and the McCollough effect. |
| Q52059125 | Cholinergic blockade and human information processing: are we asking the right questions? |
| Q37381846 | Cholinergic blockade reduces theta-gamma phase amplitude coupling and speed modulation of theta frequency consistent with behavioral effects on encoding. |
| Q38372480 | Cholinergic modulation of the hippocampal region and memory function |
| Q37826637 | Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings |
| Q41996009 | Cholinergic suppression of glutamatergic synaptic transmission in hippocampal region CA3 exhibits laminar selectivity: Implication for hippocampal network dynamics |
| Q51849530 | Chronic diazepam administration and appetitive discrimination learning: acquisition versus steady-state performance in pigeons. |
| Q36333754 | Delay-dependent working memory impairment in young-adult and aged 5-HT1BKO mice as assessed in a radial-arm water maze |
| Q51850740 | Diazepam and memory: support for a duplex model of memory. |
| Q52072395 | Dissociative effects of scopolamine on working memory in healthy young volunteers. |
| Q52102330 | Distinguishing between attentional and amnestic effects in information processing: the separate and combined effects of scopolamine and nicotine on verbal free recall. |
| Q30498575 | Drugs and human memory: effects of low doses of nitrazepam and hyoscine on retention |
| Q40909446 | Effect of diazepam and chlorpromazine on memory functions in man |
| Q38471488 | Effects of acute doses of oxiracetam in the scopolamine model of human amnesia |
| Q34282229 | Effects of atropine on the repeated acquisition and performance of response sequences in humans |
| Q34517219 | Effects of benzodiazepines on psychomotor performance |
| Q52127032 | Effects of lorazepam on memory, attention and sedation in man. |
| Q52203953 | Effects of physostigmine on memory test performance in normal volunteers. |
| Q52081590 | Effects of physostigmine on stimulus encoding in a memory-scanning task |
| Q49141055 | Effects of scopolamine, pilocarpine, and oxotremorine on the exploratory behavior of two psychogenetically selected lines of rats in a complex maze |
| Q52213154 | Effects of two antidepressants on memory performance in depressed outpatients: a double-blind study. |
| Q51778262 | Effects on memory following a single oral dose of diazepam. |
| Q80608529 | Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia |
| Q41349709 | Encoding and retrieval of episodic memories: role of cholinergic and GABAergic modulation in the hippocampus |
| Q44604398 | Enhanced cholinergic suppression of previously strengthened synapses enables the formation of self-organized representations in olfactory cortex |
| Q46947447 | Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women |
| Q28318950 | Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: Effects of concurrent administration of physostigmine and methylphenidate with scopolamine |
| Q43078844 | Exploring Bhavana samskara using Tinospora cordifolia and Phyllanthus emblica combination for learning and memory in mice |
| Q34457497 | Free recall and recognition in a network model of the hippocampus: simulating effects of scopolamine on human memory function. |
| Q33898082 | Functional MRI detection of pharmacologically induced memory impairment |
| Q35598423 | High acetylcholine levels set circuit dynamics for attention and encoding and low acetylcholine levels set dynamics for consolidation |
| Q40904824 | Human Serial Learning: Enhancement with Arecholine and Choline Impairment with Scopolamine |
| Q30473426 | Human models as tools in the development of psychotropic drugs |
| Q38473821 | Implicit and explicit memory in young, old, and demented adults |
| Q40096599 | Interactions of benzodiazepines on psychomotor skills |
| Q41729631 | Intubation and other experiences in cardiac surgery: the consumer’s views |
| Q24598925 | Leveraging the cortical cholinergic system to enhance attention |
| Q51631318 | Lorazepam and diazepam effects on memory acquisition in priming tasks. |
| Q39810907 | Mechanisms of Action of Benzodiazepines |
| Q51832043 | Memory performance in individuals with primary degenerative dementia: its similarity to diazepam-induced impairments. |
| Q45719974 | Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood |
| Q34355481 | Modes and models of forebrain cholinergic neuromodulation of cognition. |
| Q47871517 | Modulation of Hippocampal Circuits by Muscarinic and Nicotinic Receptors. |
| Q52205599 | Multiple memory deficits in Alzheimer-type dementia: implications for pharmacotherapy. |
| Q41094159 | Neurological and psychiatric adverse effects of anaesthetics: epidemiology and treatment |
| Q36290623 | Neuromodulation of I(h) in layer II medial entorhinal cortex stellate cells: a voltage-clamp study. |
| Q41933124 | Neuromodulatory control of neocortical microcircuits with activity-dependent short-term synaptic depression |
| Q41597454 | Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. |
| Q46291726 | Nicotinic-dopaminergic relationships and radial-arm maze performance in rats |
| Q41353342 | Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia |
| Q28388723 | Performance tests |
| Q39784796 | Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects. |
| Q38578433 | Pharmacological models in Alzheimer's disease research |
| Q51133249 | Pharmacological models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on word valence ratings, priming and recall. |
| Q40294192 | Psychomotor function and psychoactive drugs |
| Q52103049 | Qualitative analysis of scopolamine-induced amnesia. |
| Q52103597 | RU 41 656 does not reverse the scopolamine-induced cognitive deficit in healthy volunteers |
| Q51433667 | Regional brain activity during shape recognition impaired by a scopolamine challenge to encoding. |
| Q51124047 | Scopolamine and lorazepam exert different patterns of effects in a test battery assessing stages of information processing |
| Q48469547 | Scopolamine deficits in negative patterning discrimination: evidence for a role of the central cholinergic system in retention but not acquisition of non-spatial configural association learning |
| Q49115559 | Scopolamine disrupts maintenance of attention rather than memory processes |
| Q46738259 | Scopolamine reduces persistent activity related to long-term encoding in the parahippocampal gyrus during delayed matching in humans. |
| Q52079352 | Scopolamine-induced amnesia in humans: lack of effects of the benzodiazepine receptor antagonist β-carboline ZK 93426. |
| Q51699172 | Selective dissociations of sedation and amnesia following ingestion of diazepam |
| Q38498840 | Selective effects of cholinergic treatment on verbal memory in posttraumatic amnesia. |
| Q43241914 | Some effects of atropine on short-term memory |
| Q58089183 | Specific Basal Forebrain-Cortical Cholinergic Circuits Coordinate Cognitive Operations |
| Q51163750 | Study of the potential reversal of triazolam memory and cognitive deficits by RU 41 656 in healthy subjects |
| Q52014507 | Synergistic anticholinergic and antiserotonergic effects in humans |
| Q39756011 | The cholinergic neurotransmitter system in human memory and dementia: a review |
| Q41649593 | The effects and interactions of scopolamine, physostigmine and methamphetamine on human memory |
| Q34402545 | The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills |
| Q47649126 | The effects of intravenous diazepam and hyoscine upon human memory |
| Q42132990 | The effects of scopolamine on working memory in healthy young volunteers |
| Q43168345 | The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects |
| Q44842565 | The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction |
| Q26781586 | The role of REM sleep theta activity in emotional memory |
| Q52033642 | The role of cholinergic systems in visuospatial processing and memory. |
| Q36489645 | The role of interactions between the cholinergic system and other neuromodulatory systems in learing and memory |
| Q52110190 | The use of a scopolamine model to study the potential nootropic effects of aniracetam and piracetam in healthy volunteers. |
| Q40551802 | What can modern statistics offer imaging neuroscience? |
| Q51984955 | [Medication and memory: interactions among the elderly]. |
Search more.